Yan G, Zhu T, Zhou J, Li X, Wen Z, Miuhuitijiang B
J Cell Mol Med. 2024; 28(20):e70186.
PMID: 39470578
PMC: 11520440.
DOI: 10.1111/jcmm.70186.
Geng H, Tang D, Li K, Xu C, Wang C, Zhang X
BMC Med Genomics. 2024; 17(1):249.
PMID: 39394131
PMC: 11468214.
DOI: 10.1186/s12920-024-01990-9.
Launonen K, Varis V, Aaltonen N, Niskanen E, Varjosalo M, Paakinaho V
Nucleic Acids Res. 2024; 52(16):9519-9535.
PMID: 39106160
PMC: 11381344.
DOI: 10.1093/nar/gkae653.
Lishman-Walker E, Coffey K
Cancers (Basel). 2024; 16(13).
PMID: 39001502
PMC: 11240421.
DOI: 10.3390/cancers16132436.
Camilo V, Pacheco M, Moreira-Silva F, Outeiro-Pinho G, Gaspar V, Mano J
Biomolecules. 2023; 13(10).
PMID: 37892208
PMC: 10605369.
DOI: 10.3390/biom13101526.
Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancer.
Leach D, Fernandes R, Bevan C
Endocr Oncol. 2023; 2(1):R112-R131.
PMID: 37435460
PMC: 10259329.
DOI: 10.1530/EO-22-0065.
Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models.
Xu P, Yang J, Ning S, Chen B, Nip C, Wei Q
Pharmacol Res. 2023; 189:106692.
PMID: 36773708
PMC: 10162009.
DOI: 10.1016/j.phrs.2023.106692.
Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future?.
Pozas J, Alvarez Rodriguez S, Albarran Fernandez V, Burgos J, Santoni M, Manneh Kopp R
Cancers (Basel). 2022; 14(24).
PMID: 36551557
PMC: 9776956.
DOI: 10.3390/cancers14246071.
Posttranslational modifications in pathogenesis of PCOS.
Wei H, Huo P, Liu S, Huang H, Zhang S
Front Endocrinol (Lausanne). 2022; 13:1024320.
PMID: 36277727
PMC: 9585718.
DOI: 10.3389/fendo.2022.1024320.
Drug resistance in metastatic castration-resistant prostate cancer: an update on the status quo.
Yehya A, Ghamlouche F, Zahwe A, Zeid Y, Wakimian K, Mukherji D
Cancer Drug Resist. 2022; 5(3):667-690.
PMID: 36176747
PMC: 9511807.
DOI: 10.20517/cdr.2022.15.
Epigenetic Coregulation of Androgen Receptor Signaling.
Fernandes R, Leach D, Bevan C
Adv Exp Med Biol. 2022; 1390:277-293.
PMID: 36107325
DOI: 10.1007/978-3-031-11836-4_16.
Female Reproductive Systems: Hormone Dependence and Receptor Expression.
Kuan K, Saunders P
Adv Exp Med Biol. 2022; 1390:21-39.
PMID: 36107311
DOI: 10.1007/978-3-031-11836-4_2.
Topological dynamics of an intrinsically disordered N-terminal domain of the human androgen receptor.
Sheikhhassani V, Scalvini B, Ng J, Heling L, Ayache Y, Evers T
Protein Sci. 2022; 31(6):e4334.
PMID: 35634773
PMC: 9134807.
DOI: 10.1002/pro.4334.
A Review of the Pathophysiological Mechanisms Underlying Castration-resistant Prostate Cancer.
Crowley F, Sterpi M, Buckley C, Margetich L, Handa S, Dovey Z
Res Rep Urol. 2021; 13:457-472.
PMID: 34235102
PMC: 8256377.
DOI: 10.2147/RRU.S264722.
Androgen signaling uses a writer and a reader of ADP-ribosylation to regulate protein complex assembly.
Yang C, Jividen K, Kamata T, Dworak N, Oostdyk L, Remlein B
Nat Commun. 2021; 12(1):2705.
PMID: 33976187
PMC: 8113490.
DOI: 10.1038/s41467-021-23055-6.
Huaier Extract Inhibits Prostate Cancer Growth Targeting AR/AR-V7 Pathway.
Liu Z, Liu C, Yan K, Liu J, Fang Z, Fan Y
Front Oncol. 2021; 11:615568.
PMID: 33708629
PMC: 7940541.
DOI: 10.3389/fonc.2021.615568.
Post-Translational Modifications That Drive Prostate Cancer Progression.
Samarzija I
Biomolecules. 2021; 11(2).
PMID: 33572160
PMC: 7915076.
DOI: 10.3390/biom11020247.
Using biochemistry and biophysics to extinguish androgen receptor signaling in prostate cancer.
Asangani I, Blair I, Van Duyne G, Hilser V, Moiseenkova-Bell V, Plymate S
J Biol Chem. 2021; 296:100240.
PMID: 33384381
PMC: 7949100.
DOI: 10.1074/jbc.REV120.012411.
Quercetin-Resveratrol Combination for Prostate Cancer Management in TRAMP Mice.
Singh C, Chhabra G, Ndiaye M, Siddiqui I, Panackal J, Mintie C
Cancers (Basel). 2020; 12(8).
PMID: 32748838
PMC: 7465013.
DOI: 10.3390/cancers12082141.
Stabilization of ADAM9 by N-α-acetyltransferase 10 protein contributes to promoting progression of androgen-independent prostate cancer.
Lin Y, Wen Y, Chu C, Tung M, Yang Y, Hua K
Cell Death Dis. 2020; 11(7):591.
PMID: 32719332
PMC: 7385149.
DOI: 10.1038/s41419-020-02786-2.